Showing results (181-190 of 447) with videos related to
Sort By:
Pageof 45
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2004
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of PtenStéphanie A Backman, Danny Ghazarian, Kelvin So, et al.Clinical Lung Cancer|August 10, 2016
A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non-Small-Cell Lung CancerKit Man Wong, Keyue Ding, Suzanne Li, et al.NPJ Precision Oncology|November 20, 2025
MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancerMing-Sound Tsao, Lynette Sholl, Michelle Shiller, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2026
Update on pleural epithelioid mesothelioma: New insights for diagnosis and patient managementFrancoise Galateau Sallé, Mary Beth Beasley, Luka Brcic, et al.Lung Cancer (Amsterdam, Netherlands)|June 27, 2003
Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicityShirley M H Sy, Nathalie Wong, Tony S K Mok, et al.Oncogene|July 13, 2004
Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasisJiang Liu, Fiona Blackhall, Isolde Seiden-Long, et al.Respiratory Medicine|September 30, 2021
Stratification and management of patients ineligible for lung cancer screeningReenika Aggarwal, Andrew Cl Lam, Jingyue Huang, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 28, 2012
Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissueGord Fehringer, Geoffrey Liu, Melania Pintilie, et al.The Journal of Clinical Investigation|August 4, 2010
Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 statusZhe Jiang, Tao Deng, Robert Jones, et al.Journal of the National Cancer Institute|February 18, 2010
Economic analysis: randomized placebo-controlled clinical trial of erlotinib in advanced non-small cell lung cancerPenelope A Bradbury, Dongsheng Tu, Lesley Seymour, et al.Pageof 45